Table 5

Test characteristics of clinical decision rules

SensitivitySpecificityPPVNPVLR (+)LR (−)
PESI*(ref. 8)
Primary outcome71% (61–0.80%)58% (51–65%)47% (39–55%)80% (72–86%)1.71 (1.39–2.11)0.49 (0.35–0.68)
Severe outcome78% (58–91%)51% (45–57%)14% (09–20%)96% (91–98%)1.58 (1.25–2.01)0.44 (0.21–0.89)
30-day mortality100% (74–100%)51% (45–56%)08% (04–13%)100% (97–100%)2.02 (1.80–2.27)
sPESI(ref. 12)
Primary outcome80% (71–87%)42% (35–49%)41% (34–49%)80% (71–88%)1.37 (1.18–1.60)0.48 (0.31–0.73)
Severe outcome81% (62–94%)36% (30–42%)11% (07–16%)95% (89–98%)1.27 (1.04–1.55)0.52 (0.23–1.16)
30-day mortality100% (74–10%)36% (30–42%)06% (03–11%)100% (96–100%)1.56 (1.43–1.70)
Geneva(ref. 3)
Primary outcome39% (29–49%)84% (78–89%)55% (43–67%)73% (66–78%)2.38 (1.59–3.55)0.73 (0.62–0.87)
Severe outcome44% (25–65%)78% (73–83%)17% (09–28%)93% (88–96%)2.04 (1.27–3.29)0.71 (0.50–1.00)
30-day mortality67% (35–90%)78% (73–83%)11% (05–21%)98% (96–100%)3.06 (1.94–4.84)0.43 (0.19–0.95)
  • On receiver operating characteristic (ROC) curve analysis, areas under the curve (AUC) for the composite outcome were PESI=0.68, sPESI=0.69 and Geneva Prognostic Rule=0.64. For severe outcomes, the AUC were PESI=0.65, sPESI=0.67 and Geneva Prognostic Rule=0.59. For 30-day death, the AUC were PESI=0.84, sPESI=0.82 and Geneva Prognostic Rule=0.78.

  • Low risk was defined as PESI category I–II (≤85 points).8 *PESI categories are I: ≤65 points; II: 66–85 points; III: 86–105 points; IV: 106–125 points and V: ≥126 points. Low-risk sPESI was defined as <1 point.12 Low-risk Geneva Prognostic Rule was defined as ≤2 points.3

  • Positive and negative predictive values were based on the prevalence in our study sample.

  • LR, likelihood ratio; NPV, negative predictive value; PESI, pulmonary embolism severity index; PPV, positive predictive value; sPESI, simplified pulmonary embolism severity index.